Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCW4A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $75,313
Award facts
- Contract value 100% obligated
- $75,312.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 27, 2025, for the supply of Kesimpta 20 mg/0.4 mL pens with a ceiling value of $75,312.84 under a firm fixed-price delivery order contract type. The award was made without a set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a prime contract value of $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
This delivery order represents a routine fulfillment of pharmaceutical supply needs under the broader DLA Medical Supply Chain program. Kesimpta is a specialty medication indicated for multiple sclerosis treatment, reflecting AmerisourceBergen Drug Corp's established role in supplying specialty pharmaceuticals and medical products to support Department of Defense and other federal healthcare systems. The delivery order is scheduled for ultimate completion by December 29, 2025, with an expected completion timeframe of approximately two days from the award date.
Quick answers
Who was awarded contract SPE2DR26FCW4A?
SPE2DR26FCW4A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 27, 2025.
How much is contract SPE2DR26FCW4A worth?
The government has obligated $75,313 on SPE2DR26FCW4A.
Is contract SPE2DR26FCW4A an order under another contract?
Yes. SPE2DR26FCW4A is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCW4A competed?
The extent of competition for SPE2DR26FCW4A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award